1.0(top 50%)
impact factor
2.2K(top 10%)
papers
31.1K(top 10%)
citations
67(top 10%)
h-index
1.2(top 50%)
extended IF
2.4K
all documents
32.5K
doc citations
102(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Xenogeneic extracellular matrix as a scaffold for tissue reconstructionTransplant Immunology2004662
2Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in manTransplant Immunology1993339
3High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cellsTransplant Immunology2003280
4Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: a technical reportTransplant Immunology1998252
5ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphismsTransplant Immunology1999234
6Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findingsTransplant Immunology1997214
7Advances in tissue engineering of blood vessels and other tissuesTransplant Immunology1997190
8Pathways of allorecognition: implications for transplantation toleranceTransplant Immunology2002186
9Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolateTransplant Immunology2008181
10Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantationTransplant Immunology2007173
11Second Report (1998–2006) of the International Registry of Hand and Composite Tissue TransplantationTransplant Immunology2007160
12Natural killer cells and their receptorsTransplant Immunology2002159
13HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanismsTransplant Immunology2005157
14Hepatic tissue engineeringTransplant Immunology2004151
15A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactionsTransplant Immunology1999142
16Microarray analysis of MicroRNA expression in acute rejection after renal transplantationTransplant Immunology2008140
17Muscle-derived stem cells for musculoskeletal tissue regeneration and repairTransplant Immunology2004138
18The effect of panel reactive antibodies and the donor specific crossmatch on graft survival after heart and heart-lung transplantationTransplant Immunology1993134
19Immunological aspects of blood transfusionsTransplant Immunology2002124
20Heart valve tissue engineeringTransplant Immunology2004121
21Xenotransplantation of solid organs in the pig-to-primate modelTransplant Immunology2009121
22The role of natural anti-galα1–3gal antibodies in hyperacute rejection of pig-to-baboon cardiac xenotransplantsTransplant Immunology1997116
23Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeysTransplant Immunology2003116
24Human embryonic stem cell-derived oligodendrocyte progenitors for the treatment of spinal cord injuryTransplant Immunology2005114
25Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cellsTransplant Immunology1997113
26IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivoTransplant Immunology2004109
27Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32)Transplant Immunology1998108
28Tolerance induction in clinical transplantationTransplant Immunology2004105
29Tolerance versus immune response — MicroRNAs as important elements in the regulation of the HLA-G gene expressionTransplant Immunology2009105
30The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in miceTransplant Immunology2007102
31Rat CD8+ FOXP3+ T suppressor cells mediate tolerance to allogeneic heart transplants, inducing PIR-B in APC and rendering the graft invulnerable to rejectionTransplant Immunology200498
32Tryptophan catabolism generates autoimmune-preventive regulatory T cellsTransplant Immunology200697
33Clinical tolerance following liver transplantation: Long term results and future prospectsTransplant Immunology200796
34Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatchesTransplant Immunology200595
35Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allograftsTransplant Immunology199594
36Clinical relevance of pretransplant anti-HLA donor-specific antibodies: Does C1q-fixation matter?Transplant Immunology201394
37Generation and function of antigen-specific suppressor and regulatory T cellsTransplant Immunology200393
38Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantationTransplant Immunology200288
39CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 responseTransplant Immunology200388
40The molecular genetics of blood group polymorphismTransplant Immunology200587
41Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation modelTransplant Immunology201186
42Immunology of pregnancy—pregnancy as a remission inducing agent in rheumatoid arthritisTransplant Immunology200285
43Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTDTransplant Immunology200784
44Activation of Tim-3–Galectin-9 pathway improves survival of fully allogeneic skin graftsTransplant Immunology200884
45Distribution of the major xenoantigen (gal(α1–3)gal) for pig to human xenograftsTransplant Immunology199483
46Natural anti-galactose α1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenograftsTransplant Immunology200283
47A novel strategy against ischemia and reperfusion injury: cytoprotection with heme oxygenase systemTransplant Immunology200283
48Rejection and recipient ageTransplant Immunology200283
49Cellular therapies for liver replacementTransplant Immunology200483
50The 25th anniversary of the Eurotransplant Acceptable Mismatch program for highly sensitized patientsTransplant Immunology201582